Clinical evaluation of an oral combined antihistaminic sympathomimetic preparation.
D000284:Administration, Oral; D000328:Adult; D001977:Brompheniramine / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010665:Phenylpropanolamine / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011725:Pyridines / Q000627:therapeutic use; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D013997:Time Factors
D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D010919:Placebos; D011725:Pyridines; D010665:Phenylpropanolamine; D001977:Brompheniramine